Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
American Journal of Hematology|December 6, 2011
Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbα antibodiesQingshu Zeng, Lingyan Zhu, Lili Tao, et al.
Therapeutic Advances in Medical Oncology|February 6, 2023
TRK inhibitor in a patient with metastatic triple-negative breast cancer and <i>NTRK</i> fusions identified <i>via</i> cell-free DNA analysisArielle J Medford, Lauren Oshry, Baris Boyraz, et al.
NPJ Precision Oncology|September 22, 2021
Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analysesSiang-Boon Koh, Brian N Dontchos, Veerle Bossuyt, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast CancerBogang Wu, Win Thant, Elena Bitman, et al.
Nature Cancer|October 29, 2021
Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapyJason I Griffiths, Jinfeng Chen, Patrick A Cosgrove, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2019
<i>FGFR1</i> Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR<sup>+</sup>) Breast CancerJoshua Z Drago, Luigi Formisano, Dejan Juric, et al.
Cancer Discovery|August 15, 2018
A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast CancerTanya T Kwan, Aditya Bardia, Laura M Spring, et al.
Head & Neck|February 2, 2011
Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancerGregory T Wolf, Willard E Fee, Robert W Dolan, et al.
Breast Cancer Research and Treatment|May 29, 2025
Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomesArielle J Medford, Marko Velimirovic, Yifat Gefen, et al.
Nature Cell Biology|January 2, 2019
Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer modelsIoanna Keklikoglou, Chiara Cianciaruso, Esra Güç, et al.
Pageof 18